Misplaced Pages

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "MIDAS Trial" – news · newspapers · books · scholar · JSTOR (February 2014) (Learn how and when to remove this message) The topic of this article may not meet Misplaced Pages's general notability guideline. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "MIDAS Trial" – news · newspapers · books · scholar · JSTOR (February 2014) (Learn how and when to remove this message) (Learn how and when to remove this message)

The MIDAS Trial is a randomized controlled trial in Manchester, England using Motivational Interventions for Drugs & Alcohol misuse in Schizophrenia. It is led by Professor Christine Barrowclough and operates in both Manchester and London.

The trial is, along with the Danish CapOpus trial, among the only trials aimed at this particular group of comorbid substance abusers with schizophrenia.

This article about a UK medical organisation, hospital, or association is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Clinical trials
• Psychology experiments
• United Kingdom medical organisation stubs